VanEck Biotech ETF (NASDAQ:BBH – Get Free Report) saw strong trading volume on Thursday. 13,165 shares traded hands during mid-day trading, an increase of 61% from the average daily volume of 8,153 shares. The stock last traded at $244.8160 and had previously closed at $244.91.
VanEck Biotech ETF Trading Down 0.1%
The stock’s fifty day moving average price is $244.76 and its 200 day moving average price is $210.54.
Institutional Investors Weigh In On VanEck Biotech ETF
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Kestra Advisory Services LLC boosted its holdings in shares of VanEck Biotech ETF by 3.0% in the first quarter. Kestra Advisory Services LLC now owns 3,405 shares of the company’s stock worth $640,000 after buying an additional 98 shares during the last quarter. Harbour Investments Inc. bought a new stake in VanEck Biotech ETF during the third quarter valued at approximately $38,000. Global Retirement Partners LLC purchased a new stake in VanEck Biotech ETF during the third quarter valued at approximately $41,000. Coastline Trust Co bought a new position in VanEck Biotech ETF in the third quarter worth approximately $46,000. Finally, CoreCap Advisors LLC bought a new position in VanEck Biotech ETF in the third quarter worth approximately $46,000. Hedge funds and other institutional investors own 32.05% of the company’s stock.
About VanEck Biotech ETF
The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.
Recommended Stories
- Five stocks we like better than VanEck Biotech ETF
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
- 3 Niche ETFs Are Beating the S&P 500, and Their Strategies Are Anything but Typical
Receive News & Ratings for VanEck Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
